Most patients find that side effects decrease significantly after 6-12 weeks while weight loss benefits continue to compound
In the SURMOUNT-1 trial , which included people without diabetes who were using tirzepatide for weight loss, dizziness also occurred in a small number of participants
Although challenges remain in device durability, biocompatibility, and clinical translation pathways, this strategy holds considerable promise as a potential disease-modifying therapy for KOA and may offer a novel, minimally invasive treatment option for patients in the future
This interaction involves the lipopolysaccharide transport during outer membrane biogenesis, distinguishing them from other antimicrobial peptides primarily acting through membranolytic activity
Scratching Induces Overactivity in Motor-Related Regions and Reward System in Chronic Itch Patients
Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo